Efficacy and safety of fexagratinib (Fexa) in Chinese patients (pts) with metastatic or unresectable urothelial carcinoma (mUC) harboring FGF receptor (FGFR) genetic alterations.

Authors: Xiaojie Bian, Shanshan Wang, Dingwei Ye, Shaoxing Zhu, Xin Gou, Benkang Shi, Jun Xiao, Bin Hu, Xianling Liu, Shusuan Jiang, Haitao Liu, Chaohong He, Xiaoping Zhang, Zhiwen Chen, Xinli Kang, Changfu Li, Ning Xu, Yong Yang, Kun Li, Qilin Wang

Published: 2025-02-18

DOI: 10.1200/jco.2025.43.5_suppl.790

Source: Full article

---

Abstract

790